XML 39 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (Loss) Per Share (Tables)
9 Months Ended
Sep. 27, 2020
Earnings (Loss) Per Share  
Schedule of Earnings (Loss) Per Share, Basic and Diluted

The calculations of basic and diluted earnings (loss) per common share are as follows (in thousands, except per-share data):

Three Months Ended

Nine Months Ended

September 27,

September 29,

September 27,

September 29,

2020

    

2019

    

2020

    

2019

Basic earnings (loss) per common share

Net income attributable to the Company

$

15,708

$

385

$

44,765

$

7,008

Dividends paid to participating securities and accretion

(3,548)

(3,473)

(10,546)

(9,029)

Net income attributable to participating securities

 

(703)

 

 

(1,809)

 

Net income (loss) attributable to common shareholders

$

11,457

$

(3,088)

$

32,410

$

(2,021)

Basic weighted average common shares outstanding

 

32,616

 

31,601

 

32,347

 

31,581

Basic earnings (loss) per common share

$

0.35

$

(0.10)

$

1.00

$

(0.06)

Diluted earnings (loss) per common share

Net income (loss) attributable to common shareholders

$

11,457

$

(3,088)

$

32,410

$

(2,021)

Weighted average common shares outstanding

 

32,616

 

31,601

 

32,347

 

31,581

Dilutive effect of outstanding equity awards (a)

 

355

 

 

296

 

Diluted weighted average common shares outstanding (b)

 

32,971

 

31,601

 

32,643

 

31,581

Diluted earnings (loss) per common share

$

0.35

$

(0.10)

$

0.99

$

(0.06)

(a)Excludes 132 equity awards for the nine months ended September 27, 2020 as the effect of including such awards would have been anti-dilutive.
(b)The Company had 252.5 shares of Series B Preferred Stock outstanding as of September 27, 2020 and December 29, 2019. For the fully diluted calculation, the Series B Preferred stock dividends were added back to net income (loss) attributable to common shareholders. The Company then applied the if-converted method to calculate dilution on the Series B Preferred Stock, which resulted in 5.0 million additional common shares.  This calculation was anti-dilutive for both periods presented and as such was excluded.